| 通報(bào)號: G/TBT/N/JPN/499 |
ICS號: 11
|
發(fā)布日期: 2015-09-16
|
截至日期: 2015-09-24
|
通報(bào)成員: 日本
|
目標(biāo)和理由: 保護(hù)人類安全和健康
|
內(nèi)容概述: 部分修訂放射性藥品最低要求,增加了最近批準(zhǔn)的放射性藥品標(biāo)準(zhǔn)。
|
正文:
| 世界貿(mào)易組織 |
G/TBT/N/JPN/499
2015-09-16
15-4742
|
| |
| 技術(shù)性貿(mào)易壁壘 |
原文:英語
|
通 報(bào)
以下通報(bào)根據(jù)TBT協(xié)定第10.6條分發(fā)
| 1. |
通報(bào)成員: 日本
如可能,列出涉及的地方政府名稱 ( 3.2條和7.2 條):
|
| 2. |
負(fù)責(zé)機(jī)構(gòu):厚生勞動(dòng)?。∕HLW)
|
| 3. |
通報(bào)依據(jù)條款:2.9.2
|
| 4. |
覆蓋的產(chǎn)品: 藥品。 HS: 30
HS編碼:30 ICS編碼:11
|
| 5. |
通報(bào)標(biāo)題: 部分修訂放射性藥品最低要求
語言:英語 頁數(shù):1 鏈接網(wǎng)址:
|
| 6. |
內(nèi)容簡述:部分修訂放射性藥品最低要求,增加了最近批準(zhǔn)的放射性藥品標(biāo)準(zhǔn)。
|
| 7. |
目標(biāo)與理由:為了公眾健康和衛(wèi)生規(guī)定了藥品必須特別注意的生產(chǎn)加工、特性、質(zhì)量、存儲標(biāo)準(zhǔn)及其它標(biāo)準(zhǔn)(放射性藥品)。
|
| 8. |
相關(guān)文件: 關(guān)于藥品、醫(yī)療器械、再生細(xì)胞治療產(chǎn)品、基因治療產(chǎn)品和化妝品質(zhì)量保證、功效和安全的法案。批準(zhǔn)時(shí)本修訂公布在官方公報(bào)上。
|
| 9. |
擬批準(zhǔn)日期:放射性藥品批準(zhǔn)之日
擬生效日期:放射性藥品批準(zhǔn)之日
|
| 10. |
意見反饋截止日期: 2015/09/24
|
| 11. |
文本可從以下機(jī)構(gòu)得到:
|
|
正文(英):
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6
|
1.
|
Notifying Member: Japan
If applicable, name of local government involved (Article 3.2 and 7.2):
|
|
2.
|
Agency responsible: Ministry of Health, Labour and Welfare
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:
|
|
3.
|
Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], other:
|
|
4.
|
Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Pharmaceutical products (HS: 30)
|
|
5.
|
Title, number of pages and language(s) of the notified document: Partial amendment to the Minimum Requirements for Radiopharmaceuticals (1 pages, in English)
|
|
6.
|
Description of content: The minimum requirements for radiopharmaceuticals are to be partially amended to add the standards for a radiopharmaceutical to be newly approved.
|
|
7.
|
Objective and rationale, including the nature of urgent problems where applicable: To establish the standard for manufacturing process, properties, quality, storage and others of drugs to which special attention must be paid for the attainment of public health and sanitation (radiopharmaceuticals).
|
|
8.
|
Relevant documents: The act on securing quality, efficacy and safety of pharmaceuticals, medical devices, regenerative and cellular therapy products, gene therapy products, and cosmetics. This amendment will be published in "KAMPO" (Official Gazette) when adopted.
|
|
9.
|
Proposed date of adoption: The same day as the approval of the radiopharmaceutical
Proposed date of entry into force: The same day as the approval of the radiopharmaceutical
|
|
10.
|
Final date for comments: 24 September 2015
|
|
11.
|
Texts available from: National enquiry point [X] or address, telephone and fax numbers and email and website addresses, if available, of other body:
Japan Enquiry Point
International Trade Division
Economic Affairs Bureau
Ministry of Foreign Affairs
Fax: (+81 3) 5501 8343
E-mail: enquiry@mofa.go.jp
https://members.wto.org/crnattachments/2015/TBT/JPN/15_3631_00_e.pdf
|
|
| |
|
| |
|
|
|
本網(wǎng)維權(quán)及免責(zé)聲明:
①凡本網(wǎng)所有原始/編譯文章及圖片、圖表的版權(quán)均屬江蘇省技術(shù)性貿(mào)易措施信息平臺(www.tbtguide.com)所有,如要轉(zhuǎn)載,需注明"信息來源:江蘇省技術(shù)性貿(mào)易措施信息平臺"或"信息來源:tbtguide"。違反上述規(guī)定者,本網(wǎng)將保留追究其侵權(quán)責(zé)任的權(quán)利。
②凡本網(wǎng)注明"信息來源:XXX(非tbtguide)"的作品,均轉(zhuǎn)載自其他媒體,轉(zhuǎn)載目的在于傳遞更多的信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對其真實(shí)性負(fù)責(zé)。
聯(lián)系E-mail:js_wto@163.com |